Role of Orexin-A in Hypertension and Obesity

被引:38
|
作者
Roberta, Imperatore [1 ,2 ]
Letizia, Palomba [3 ]
Luigia, Cristino [1 ]
机构
[1] CNR, Inst Biomol Chem, Endocannabinoid Res Grp, Viale Campi Flegrei, I-80078 Pozzuoli, Italy
[2] Univ Sannio, Dept Sci & Technol, Benevento, Italy
[3] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy
关键词
Orexin; Obesity; Hypertension; Catecholamine; Epinephrine; Norepinephrine; ROSTRAL VENTROLATERAL MEDULLA; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; SYMPATHETIC PREGANGLIONIC NEURONS; DEPENDENT SIGNALING CASCADE; MESSENGER-RIBONUCLEIC-ACID; RENIN-ANGIOTENSIN SYSTEM; PITUITARY-ADRENAL AXIS; CENTRAL-NERVOUS-SYSTEM; BLOOD-PRESSURE; RAT-BRAIN;
D O I
10.1007/s11906-017-0729-y
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Purpose of Review Hypertension is one of the most challenging health problems inducing cerebrovascular disease and high percentage of death when associated with diabetes, dyslipidemias, and obesity. Orexin/hypocretin is a peptide expressed by a small number of neurons of the dorsolateral hypothalamus, a brain feeding and autonomic "fight-or-flight" regulatory center. According to this function, orexin has been demonstrated to evoke cardiovascular responses, heart rate, hypertension, hyperarousal, hyperphagia, and obesity. The focus of this review is to provide an overview about the mechanism through which orexin regulates food intake and cardiovascular responses and its role in the pathogenesis of obesity and hypertension which could be of great interest to establish possible new therapies. Recent Findings In normal rats and mice, central administration of orexin increases food intake, blood pressure, and sympathetic nerve activity and these effects are blocked by selective orexin receptor antagonist SB-334867 or almorexant. Moreover, upregulation of orexin signaling, in combination with elevation of epinephrine and norepinephrine circulating levels, occurs in rats exposed to chronic stress, in models of spontaneous hypertension SHR and BPH/2J Schlager mice) and in obese mice (ob/ob or mice fed with high fat diet). Therefore, hyperactivity of orexinergic neurons could be a factor in the development of obesity and essential hypertension. Summary Because of their widespread projections to the brain regions involved in appetite and cardiovascular responses, as far down as sympathetic preganglionic neurons in the spinal cord, orexin evokes sympathetically mediated cardiovascular responses. Lasting upregulation of orexin signaling can lead to hyperphagia, obesity, and hypertensive state. Dual orexin receptor antagonists (DORAs) and selective orexin receptor antagonists (SORAs) have antihypertensive effects that could be of clinical use for regulation of food intake and hypertension, supporting the role of orexinergic neurons as critical checkpoint in the neurogenic control of metabolic and cardiovascular functions.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Orexin-A and Orexin-B During the Postnatal Development of the Rat Brain
    Stoyanova, Irina I.
    Rutten, Wim L. C.
    le Feber, Joost
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2010, 30 (01) : 81 - 89
  • [42] Sleep disorders, obesity, and aging: The role of orexin
    Nixon, Joshua P.
    Mavanji, Vijayakumar
    Butterick, Tammy A.
    Billington, Charles J.
    Kotz, Catherine M.
    Teske, Jennifer A.
    AGEING RESEARCH REVIEWS, 2015, 20 : 63 - 73
  • [43] Orexin-A causes grooming and motor activation in rats
    Jones, DNC
    Hatcher, JP
    Hatcher, PD
    Parker, F
    Hagan, JJ
    BRAIN RESEARCH, 1999, 848 (1-2) : A30 - A30
  • [44] Central orexin-A increases gastric motility in rats
    Bulbul, Mehmet
    Babygirija, Reji
    Ludwig, Kirk
    Takahashi, Toku
    PEPTIDES, 2010, 31 (11) : 2118 - 2122
  • [45] Orexin-A Exerts Equivocal Role in Atherosclerosis Process Depending on the Duration of Exposure: In Vitro Study
    Ansari, Narjes Nasiri
    Spentza, Flora
    Dimitriadis, Georgios K.
    Daskalopoulou, Aphrodite
    Karapanagioti, Angeliki
    Siasos, Gerasimos
    Lianidou, Evi
    Papavassiliou, Athanasios G.
    Kassi, Eva
    Randeva, Harpal S.
    NUTRIENTS, 2020, 12 (01)
  • [46] Expression of orexin-A and orexin receptors in the kidney and the presence of orexin-A-like immunoreactivity in human urine
    Takahashi, K
    Arihara, Z
    Suzuki, T
    Sone, M
    Kikuchi, K
    Sasano, H
    Murakami, O
    Totsune, K
    PEPTIDES, 2006, 27 (04) : 871 - 877
  • [47] Decreased plasma orexin-A levels in obese individuals
    Adam, JA
    Menheere, PPCA
    van Dielen, FMH
    Soeters, PB
    Buurman, WA
    Greve, JWM
    INTERNATIONAL JOURNAL OF OBESITY, 2002, 26 (02) : 274 - 276
  • [48] Plasma orexin-A levels and body composition in COPD
    Matsumura, T
    Nakayama, M
    Satoh, H
    Naito, A
    Kamahara, K
    Sekizawa, K
    CHEST, 2003, 123 (04) : 1060 - 1065
  • [49] Gastroprotective effect of orexin-A and heme oxygenase system
    Gemici, Burcu
    Tan, Ruken
    Birsen, Ilknur
    Izgut-Uysal, V. Nimet
    JOURNAL OF SURGICAL RESEARCH, 2015, 193 (02) : 626 - 633
  • [50] Orexin-A controls sympathetic activity and eating behavior
    Messina, Giovanni
    Dalia, Carmine
    Tafuri, Domenico
    Monda, Vincenzo
    Palmieri, Filomena
    Dato, Amelia
    Russo, Angelo
    De Blasio, Saverio
    Messina, Antonietta
    De Luca, Vincenzo
    Chieffi, Sergio
    Monda, Marcellino
    FRONTIERS IN PSYCHOLOGY, 2014, 5